Skip to content

Comunicati stampa

Stratus Medical raises $10 million Series B to complete development of new technology and fund clinical trial

di

MAGNOLIA, Texas, Feb. 4, 2026 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced a $10 million Series B financing. The financing was led by Wasatch Health Partners, a healthcare-focused investment firm pursuing growth equity and lower middle-market buyout strategies. Wasatch Health Partners invested through its Growth Fund and previously provided a $25 million convertible debt facility through its Structured Capital platform.

Stratus® Medical annuncia un accordo di distribuzione esclusiva con AMS Group SRL per l'Italia

di

Stratus Medical announces exclusive distribution agreement with AMS GROUP SRL to bring the NIMBUS® RF Multitined Expandable Electrode to Italy! 🇮🇹 AMS GROUP SRL is a leading medical device distributor focused on interventional pain therapies. AMS will launch NIMBUS in Italy with an upcoming educational education program. Will Pankey, VP of Sales for Stratus, is … Leggi tutto

Stratus® Medical annuncia un accordo di distribuzione esclusiva con Edge Medical per il Regno Unito

di

Stratus® Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom MAGNOLIA, Texas, Aug. 22, 2024 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for pain, is pleased to announce an exclusive distribution agreement with Edge Medical, a leading medical device distributor serving the United Kingdom. Edge Medical will distribute the innovative … Leggi tutto

Stratus® Medical annuncia la continua espansione della sua copertura di proprietà intellettuale in Europa con l'aggiunta al suo portafoglio di brevetti globali dell'elettrodo espandibile a radiofrequenza NIMBUS® e la registrazione di un disegno comunitario per una nuova tecnologia di piattaforma in fase di sviluppo.

di

MAGNOLIA, Texas, April 29, 2024 /PRNewswire/ — Stratus® Medical, a company focused on improving clinical outcomes for chronic pain patients by advancing radiofrequency (RF) technology for the treatment of pain, announced today the expansion of patent protection in Europe for its NIMBUS® Electrosurgical RF Multitined Expandable Electrode (“NIMBUS”) with the issuance of European Patent Numbers EP3556308 and EP3750501. Both … Leggi tutto

Nuove evidenze retrospettive per la RFA con NIMBUS, per il dolore dell'articolazione sacroiliaca, confrontando due tecniche in 182 pazienti a 12 mesi

di

Nuove prove retrospettive per l'ablazione con radiofrequenza con Nimbus, per il dolore all'articolazione sacroiliaca, confrontando due tecniche in 182 pazienti a 12 mesi. Congratulazioni agli autori per la pubblicazione di questo manoscritto, disponibile online ad accesso libero: https://esmed.org/MRA/mra/article/view/4978 Citation: Wright RE and Block JE, 2023. Radiofrequency Neurotomy for Sacroiliac Joint Pain: Twelve Month Outcomes and Comparison Between Two … Leggi tutto

Stratus® Medical annuncia l'arruolamento del primo paziente nell'importante studio comparativo, randomizzato e in doppio cieco, che confronta il dispositivo di ablazione a radiofrequenza Nimbus® con l'ablazione a radiofrequenza convenzionale per il trattamento del dolore dell'articolazione sacroiliaca

di

MAGNOLIA, Texas, March 2, 2023 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for pain, and the University of Utah, Department of Physical Medicine and Rehabilitation, announced today the first patient enrolled in the COBRA study, a double-blinded, randomized trial, comparing the bipolar treatment with Nimbus® RF Multitined Expandable Electrode to conventional radiofrequency … Leggi tutto

Stratus® Medical annuncia il rilascio del terzo brevetto statunitense per l'elettrodo espandibile multitubolare Nimbus® RF utilizzato nel trattamento del dolore

di

MAGNOLIA, Texas, Feb. 23, 2021 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, announced today that the United States Patent and Trademark Office has granted a third U.S. patent related to its Nimbus® RF Multitined Expandable Electrode. U.S. Patent No. 10,925,664, titled METHODS FOR RADIO FREQUENCY NEUROTOMY, issued on February … Leggi tutto

Stratus® Medical annuncia il rilascio di due nuovi brevetti negli Stati Uniti per l'elettrodo espandibile multitubolare Nimbus® RF utilizzato nel trattamento del dolore

di

SALT LAKE CITY, Sept. 14, 2020 /PRNewswire/ — Stratus®  Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, announced today that the United States Patent and Trademark Office has granted two new patents related to its Nimbus® RF Multitined Expandable Electrode. U.S. Patent No. 10,716,618, titled System and Methods for Tissue Ablation, issued … Leggi tutto

Stratus® Medical annuncia l'autorizzazione FDA 510k per la cannula Vesta® RF per ampliare il portafoglio prodotti e i primi trattamenti di pazienti Vesta negli Stati Uniti

di

SALT LAKE CITY, July 27, 2020 /PRNewswire/ — Stratus® Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced today FDA clearance for the Vesta RF Cannula for use in radiofrequency (RF) heat lesion procedures for the relief of pain and first Vesta patient treatments in the United States.   Vesta was developed to provide our … Leggi tutto